Nestlé Health Science has launched a new nutrition guide for patients undergoing cancer treatment in Spain.
The company collaborated with nutrition and cancer experts to publish the guide which provides diet and nutrition advice for oncology patients receiving chemotherapy and radiotherapy.
It aims to improve patients’ quality of life and reduce complications from medical treatment such as loss of muscle mass or an inability to fight infection.
Copies of the publication will be available in public hospitals, private health centres and cancer associations in the Spanish region of Catalonia.
Nestlé Health Science in Spain worked with the guide’s author Clara Joaquim, a specialist doctor for the Clinical Nutrition and Diet Unit at the Germans Trias i Pujol Hospital in eastern Catalonia.
Nestlé Health Science
This nutrition approach for cancer patients supports Nestlé Health Science’s long-term vision and ambition to develop science-based personalised nutritional solutions.
The company, established last year, is a wholly-owned subsidiary of Nestlé.
Building on its core HealthCare Nutrition business, Nestlé Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or special challenges of different life stages.
Nestlé Health Science has access to external scientific and technological know-how through Nestlé’s innovation network as well as a number of venture capital funds in which the group has interests.
Boi Ruiz, Catalonian Minister of Health, was joined by Walter Molhoek, Chief Executive Officer for Nestlé Health Science in Spain, at an event to launch the guide.
Mr Molhoek said that the aim was to extend it to other regions in Spain.
Nestlé Health Science website
Nestlé Health Science Spain website
Read more about Nestlé Health Science:
Nestlé Health Science – pioneering personalised nutrition for Solar Impulse
Nestlé Health Science acquires leading US gastrointestinal diagnostics company
Nestlé Health Science S.A. and Nestlé Institute of Health Sciences established to target new opportunity between food and pharma